source
- White House science blueprint pushes billions toward AI firms, away from university life-science researchThe White House Office of Science and Technology Policy released a report titled “Science: A New Golden Age.” The document outlines a new direction for U.S. federal science funding. The plan calls…
- Scribe Therapeutics launches $129M IPO, kicking off second-half biotech listing spreeScribe Therapeutics, a nine-year-old biotech co-founded by CRISPR pioneer Jennifer Doudna, announced its initial public offering. The company priced the IPO at about $128.7 million, raising roughl…